Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AMRX vs $BLTE | Chartloom

Compare

$AMRX vs $BLTE

Amneal Pharmaceuticals Inc · Belite Bio Inc

AMRX

Amneal Pharmaceuticals Inc

BLTE

Belite Bio Inc

Compare $AMRX vs $BLTE

Comparing Amneal Pharmaceuticals Inc and Belite Bio Inc

AMRXAmneal Pharmaceuticals Inc

BLTEBelite Bio Inc

AMRXAmneal Pharmaceuticals Inc

Market cap

$6.25B

P/E (TTM)

40.80x

Forward P/E (NTM)

19.08x

Forward P/S (NTM)

1.89x

Rev growth (TTM)

9.3%

YTD performance

54.6%

52W performance

96.3%

FCF yield

-0.2%

BLTEBelite Bio Inc

Market cap

$5.70B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

21.92x

Rev growth (TTM)

—

YTD performance

-4.6%

52W performance

91.6%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AMRX

BLTE

Detailed metrics comparison

AMRX

Amneal Pharmaceuticals Inc

BLTE

Belite Bio Inc

Market Cap

AMRX$6.25B

BLTE$5.70B

Enterprise Value

AMRX$8.85B

BLTE$5.70B

Price

AMRX$19.57

BLTE$151.87

P/E Ratio

AMRX40.80x

BLTEN/A

P/S Ratio

AMRX2.00x

BLTE0.00x

EV/Sales

AMRX2.84x

BLTE0.00x

EV/EBITDA

AMRX13.14x

BLTE0.00x

P/B Ratio

AMRX192.54x

BLTE7.97x

P/FCF Ratio

AMRXN/A

BLTEN/A

EV/FCF

AMRX-719.11x

BLTE0.00x

PEG Ratio

AMRX1.98x

BLTEN/A

Forward P/E (NTM)

AMRX19.08x

BLTEN/A

Forward P/S (NTM)

AMRX1.89x

BLTE21.92x

Revenue (TTM)

AMRX$3.12B

BLTE$0

Revenue Growth (YoY)

AMRX9.3%

BLTEN/A

Forward Rev Growth

AMRX9.0%

BLTE97.1%

Gross Margin (TTM)

AMRX39.3%

BLTE0.0%

Operating Margin (TTM)

AMRX14.6%

BLTE0.0%

EBITDA Margin (TTM)

AMRX21.6%

BLTE0.0%

Net Margin (TTM)

AMRX5.0%

BLTE0.0%

FCF Margin (TTM)

AMRX-0.4%

BLTEN/A

Net Income (TTM)

AMRX$157M

BLTE$-116M

FCF (TTM)

AMRX$-12M

BLTE$0

EPS (TTM)

AMRX$0.48

BLTE-$3.07

ROE (TTM)

AMRX174.6%

BLTE-2687.0%

ROA (TTM)

AMRX4.3%

BLTE-2626.0%

ROIC (TTM)

AMRX2.1%

BLTE-2687.0%

Cash

AMRX$128M

BLTE$0

Debt

AMRX$2.73B

BLTE$0

Net Cash/Debt

AMRX$-2.60B

BLTE$0

Current Ratio (TTM)

AMRX2.20x

BLTE50.02x

Quick Ratio (TTM)

AMRX1.38x

BLTE49.90x

Debt/Equity (TTM)

AMRX82.62x

BLTE0.00x

Debt/Assets (TTM)

AMRX0.0%

BLTE0.0%

Interest Coverage (TTM)

AMRXN/A

BLTEN/A

Net Debt/EBITDA (TTM)

AMRX0.00x

BLTE0.00x

Beta

AMRX1.22

BLTE-1.22

52W Performance

AMRX96.3%

BLTE91.6%

YTD Performance

AMRX54.6%

BLTE-4.6%

% from 52W High

AMRX-7.6%

BLTE-24.1%

% from 52W Low

AMRX104.7%

BLTE92.9%

Asset Turnover (TTM)

AMRX0.85x

BLTE0.00x

FCF Yield (TTM)

AMRX-0.2%

BLTE0.0%

Earnings Yield (TTM)

AMRX2.5%

BLTE-2.0%

Dividend Yield (TTM)

AMRXN/A

BLTEN/A

Rule of 40

AMRX8.9

BLTE0.0

EV/GP/RG

AMRX1.16

BLTEN/A

Ticker research

View AMRX research View BLTE research

Metric	AMRX Amneal Pharmaceuticals Inc	BLTE Belite Bio Inc
Market & Valuation
Market Cap	$6.25B	$5.70B
Enterprise Value	$8.85B	$5.70B
Price	$19.57	$151.87
P/E Ratio	40.80x	N/A
P/S Ratio	2.00x	0.00x
EV/Sales	2.84x	0.00x
EV/EBITDA	13.14x	0.00x
P/B Ratio	192.54x	7.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-719.11x	0.00x
PEG Ratio	1.98x	N/A
Forward P/E (NTM)	19.08x	N/A
Forward P/S (NTM)	1.89x	21.92x
Revenue & Growth
Revenue (TTM)	$3.12B	$0
Revenue Growth (YoY)	9.3%	N/A
Forward Rev Growth	9.0%	97.1%
Profitability
Gross Margin (TTM)	39.3%	0.0%
Operating Margin (TTM)	14.6%	0.0%
EBITDA Margin (TTM)	21.6%	0.0%
Net Margin (TTM)	5.0%	0.0%
FCF Margin (TTM)	-0.4%	N/A
Net Income (TTM)	$157M	$-116M
FCF (TTM)	$-12M	$0
EPS (TTM)	$0.48	-$3.07
ROE (TTM)	174.6%	-2687.0%
ROA (TTM)	4.3%	-2626.0%
ROIC (TTM)	2.1%	-2687.0%
Financial Health
Cash	$128M	$0
Debt	$2.73B	$0
Net Cash/Debt	$-2.60B	$0
Current Ratio (TTM)	2.20x	50.02x
Quick Ratio (TTM)	1.38x	49.90x
Debt/Equity (TTM)	82.62x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.22	-1.22
52W Performance	96.3%	91.6%
YTD Performance	54.6%	-4.6%
% from 52W High	-7.6%	-24.1%
% from 52W Low	104.7%	92.9%
Efficiency & Yields
Asset Turnover (TTM)	0.85x	0.00x
FCF Yield (TTM)	-0.2%	0.0%
Earnings Yield (TTM)	2.5%	-2.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	8.9	0.0
EV/GP/RG	1.16	N/A
Ticker research	View AMRX research	View BLTE research

Valuation

P/E Ratio

AMRX

40.80x

P/S Ratio

BLTE

0.00x

AMRX

2.00x

EV/FCF

AMRX

-719.11x

BLTE

0.00x

Growth & revenue

Revenue Growth TTM

AMRX

9.3%

Forward Revenue Growth

BLTE

97.1%

AMRX

9.0%

Profitability & performance

Gross Margin

AMRX

39.3%

BLTE

0.0%

ROE

AMRX

174.6%

BLTE

-2687.0%

FCF Yield %

BLTE

0.0%

AMRX

-0.2%

52-Week Performance

AMRX

96.3%

BLTE

91.6%

Detailed metrics comparison

AMRX

Amneal Pharmaceuticals Inc

BLTE

Belite Bio Inc

Market Cap

AMRX$6.25B

BLTE$5.70B

Enterprise Value

AMRX$8.85B

BLTE$5.70B

Price

AMRX$19.57

BLTE$151.87

P/E Ratio

AMRX40.80x

BLTEN/A

P/S Ratio

AMRX2.00x

BLTE0.00x

EV/Sales

AMRX2.84x

BLTE0.00x

EV/EBITDA

AMRX13.14x

BLTE0.00x

P/B Ratio

AMRX192.54x

BLTE7.97x

P/FCF Ratio

AMRXN/A

BLTEN/A

EV/FCF

AMRX-719.11x

BLTE0.00x

PEG Ratio

AMRX1.98x

BLTEN/A

Forward P/E (NTM)

AMRX19.08x

BLTEN/A

Forward P/S (NTM)

AMRX1.89x

BLTE21.92x

Revenue (TTM)

AMRX$3.12B

BLTE$0

Revenue Growth (YoY)

AMRX9.3%

BLTEN/A

Forward Rev Growth

AMRX9.0%

BLTE97.1%

Gross Margin (TTM)

AMRX39.3%

BLTE0.0%

Operating Margin (TTM)

AMRX14.6%

BLTE0.0%

EBITDA Margin (TTM)

AMRX21.6%

BLTE0.0%

Net Margin (TTM)

AMRX5.0%

BLTE0.0%

FCF Margin (TTM)

AMRX-0.4%

BLTEN/A

Net Income (TTM)

AMRX$157M

BLTE$-116M

FCF (TTM)

AMRX$-12M

BLTE$0

EPS (TTM)

AMRX$0.48

BLTE-$3.07

ROE (TTM)

AMRX174.6%

BLTE-2687.0%

ROA (TTM)

AMRX4.3%

BLTE-2626.0%

ROIC (TTM)

AMRX2.1%

BLTE-2687.0%

Cash

AMRX$128M

BLTE$0

Debt

AMRX$2.73B

BLTE$0

Net Cash/Debt

AMRX$-2.60B

BLTE$0

Current Ratio (TTM)

AMRX2.20x

BLTE50.02x

Quick Ratio (TTM)

AMRX1.38x

BLTE49.90x

Debt/Equity (TTM)

AMRX82.62x

BLTE0.00x

Debt/Assets (TTM)

AMRX0.0%

BLTE0.0%

Interest Coverage (TTM)

AMRXN/A

BLTEN/A

Net Debt/EBITDA (TTM)

AMRX0.00x

BLTE0.00x

Beta

AMRX1.22

BLTE-1.22

52W Performance

AMRX96.3%

BLTE91.6%

YTD Performance

AMRX54.6%

BLTE-4.6%

% from 52W High

AMRX-7.6%

BLTE-24.1%

% from 52W Low

AMRX104.7%

BLTE92.9%

Asset Turnover (TTM)

AMRX0.85x

BLTE0.00x

FCF Yield (TTM)

AMRX-0.2%

BLTE0.0%

Earnings Yield (TTM)

AMRX2.5%

BLTE-2.0%

Dividend Yield (TTM)

AMRXN/A

BLTEN/A

Rule of 40

AMRX8.9

BLTE0.0

EV/GP/RG

AMRX1.16

BLTEN/A

Ticker research

View AMRX research View BLTE research

Metric	AMRX Amneal Pharmaceuticals Inc	BLTE Belite Bio Inc
Market & Valuation
Market Cap	$6.25B	$5.70B
Enterprise Value	$8.85B	$5.70B
Price	$19.57	$151.87
P/E Ratio	40.80x	N/A
P/S Ratio	2.00x	0.00x
EV/Sales	2.84x	0.00x
EV/EBITDA	13.14x	0.00x
P/B Ratio	192.54x	7.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-719.11x	0.00x
PEG Ratio	1.98x	N/A
Forward P/E (NTM)	19.08x	N/A
Forward P/S (NTM)	1.89x	21.92x
Revenue & Growth
Revenue (TTM)	$3.12B	$0
Revenue Growth (YoY)	9.3%	N/A
Forward Rev Growth	9.0%	97.1%
Profitability
Gross Margin (TTM)	39.3%	0.0%
Operating Margin (TTM)	14.6%	0.0%
EBITDA Margin (TTM)	21.6%	0.0%
Net Margin (TTM)	5.0%	0.0%
FCF Margin (TTM)	-0.4%	N/A
Net Income (TTM)	$157M	$-116M
FCF (TTM)	$-12M	$0
EPS (TTM)	$0.48	-$3.07
ROE (TTM)	174.6%	-2687.0%
ROA (TTM)	4.3%	-2626.0%
ROIC (TTM)	2.1%	-2687.0%
Financial Health
Cash	$128M	$0
Debt	$2.73B	$0
Net Cash/Debt	$-2.60B	$0
Current Ratio (TTM)	2.20x	50.02x
Quick Ratio (TTM)	1.38x	49.90x
Debt/Equity (TTM)	82.62x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.22	-1.22
52W Performance	96.3%	91.6%
YTD Performance	54.6%	-4.6%
% from 52W High	-7.6%	-24.1%
% from 52W Low	104.7%	92.9%
Efficiency & Yields
Asset Turnover (TTM)	0.85x	0.00x
FCF Yield (TTM)	-0.2%	0.0%
Earnings Yield (TTM)	2.5%	-2.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	8.9	0.0
EV/GP/RG	1.16	N/A
Ticker research	View AMRX research	View BLTE research